Work

Phase I evaluation of lapatinib and everolimus in patients with advanced malignancies: Southwest Oncology Group trial S0528

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3553

Authors: C. J. Hoban, A. Hoering, T. W. Synold, V. Chung, D. R. Gandara, A. F. Schott, L. Kingsbury, D. Lew, P. M. LoRusso, S. M. Gadgeel

Institutions: City Of Hope National Medical Center, Wayne State University, University of Michigan, The Barbara Ann Karmanos Cancer Institute, Cancer Research And Biostatistics, UC Davis Comprehensive Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2223031152

Cites:

Cited by: 2

Related to: 10